Len May

Len May, CEO of EndoDNA and a leader in genomics and medicinal cannabis, talks about revolutionizing health through personalized DNA insights. He reveals how genetics can determine your response to cannabis and psychedelics, enhancing mental health and performance. Throughout the discussion, Len emphasizes the importance of tailored formulations, the role of the endocannabinoid system, and using genetic data to avoid adverse reactions. With compelling anecdotes, he highlights how personalized cannabis strategies can dramatically improve life quality and well-being.